Image: Shutterstock / yul38885
The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators. Intravenous Vitamin C for Patients Hospitalized With COVID-19. Two Harmonized Randomized Clinical Trials. JAMA 2023;330(18):1745-1759
